<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-43016" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Xeroderma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gade</surname>
            <given-names>Anita</given-names>
          </name>
          <aff>Stamford Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Matin</surname>
            <given-names>Taraneh</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rubenstein </surname>
            <given-names>Richard</given-names>
          </name>
          <aff>Medical College of Virginia, Richmond, VA</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Anita Gade declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Taraneh Matin declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Richard Rubenstein declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>29</day>
          <month>10</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-43016.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Xeroderma, also known as dry skin, xerosis cutis, or asteatosis, is a prevalent condition resulting from inadequate hydrolipids in the skin. This deficiency can manifest as roughness, tightness, flaking, and scaling of the skin, resulting from various factors such as age, underlying medical conditions, medications, or environmental changes. This activity provides learners with insights into the evaluation and holistic management of xeroderma, including strategies to alleviate pruritus, minimize the risk of skin infections, and ultimately improve patient outcomes. Furthermore, this activity underscores the essential contribution of the interprofessional healthcare team in efficiently addressing the complexities associated with xeroderma, thereby fostering enhanced patient care and satisfaction.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical signs and symptoms of xeroderma, including skin roughness, tightness, flaking, and scaling, to diagnose the condition accurately.</p></list-item><list-item><p>Screen patients for the risk factors and underlying causes of xeroderma, such as comorbidities, medication use, systemic diseases, and environmental exposures.</p></list-item><list-item><p>Select suitable active&#x000a0;therapeutic ingredients and products for xeroderma based on individual symptoms and preferences, the severity of xeroderma, and potential interactions.</p></list-item><list-item><p>Communicate effectively with patients to provide clear explanations about the condition, its management, and the importance of proper moisturization, thereby ensuring informed decision-making.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43016">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-43016.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Xeroderma, also known as dry skin, xerosis cutis, or asteatosis, is a prevalent condition resulting from inadequate hydrolipids in the skin. This deficiency can manifest as roughness, tightness, flaking, and scaling of the skin.<xref ref-type="bibr" rid="article-43016.r1">[1]</xref><xref ref-type="bibr" rid="article-43016.r2">[2]</xref> The condition may lead to pruritus, resulting in excoriations and an elevated susceptibility to skin infections. Xeroderma has a multifactorial etiology, often triggered by environmental changes, underlying diseases, medications, or advanced age.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref>&#x000a0;</p>
        <p>Although xeroderma can impact all body parts, it tends to occur more frequently in areas with fewer sebaceous glands, such as the lower legs, forearms, hands, and feet.<xref ref-type="bibr" rid="article-43016.r3">[3]</xref> The primary treatment approach for xeroderma involves using moisturizers, which effectively repair&#x000a0;the epidermal skin barrier and restore proper hydration.<xref ref-type="bibr" rid="article-43016.r4">[4]</xref></p>
      </sec>
      <sec id="article-43016.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Many people worldwide will encounter xeroderma at some point in their lives, primarily due to the depletion of lipids in the skin.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref><xref ref-type="bibr" rid="article-43016.r5">[5]</xref> Xeroderma can present as either acute or chronic, and its onset can be attributed to diverse factors, which&#x000a0;are elaborated upon below.</p>
        <p>
<bold>Exogenous Factors</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Skin cleansing:&#x000a0;Repeated and lengthy hot showers and the use of harsh, alkaline soaps.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Environmental factors:&#x000a0;Exposure to cold weather, low humidity, dry indoor heating, and intense sunlight.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Occupational factors:&#x000a0;Contact with irritant agents, such as chemicals used in hairdressing or housekeeping.</p>
          </list-item>
        </list>
        <p>
<bold>Endogenous&#x000a0;Factors</bold>
</p>
        <p>
<bold>Skin diseases:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory skin disorders:&#x000a0;Atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis, dyshidrotic eczema, seborrheic dermatitis, and psoriasis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Chronic-phase infectious skin conditions:&#x000a0;Scabies, bacterial, or fungal infections.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Genodermatoses:&#x000a0;Xeroderma pigmentosum and ichthyoses.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Neoplasms:&#x000a0;Cutaneous T-cell lymphoma.</p>
          </list-item>
        </list>
        <p>
<bold>Internal or systemic diseases:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Endocrine or metabolic: Diabetes mellitus, hypothyroidism, hyperthyroidism, primary biliary cholangitis, cholestasis, hyperparathyroidism, and renal failure.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory:&#x000a0;Crohn disease and ulcerative colitis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Infections:&#x000a0;HIV and hepatitis B or C virus.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hormonal:&#x000a0;Pregnancy and menopause.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Hematologic:&#x000a0;Myeloproliferative disorders, multiple myeloma, and Hodgkin and non-Hodgkin lymphomas.</p>
          </list-item>
        </list>
        <p>
<bold>Psychiatric diseases:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Obsessive-compulsive disorders:&#x000a0;Excessive skin washing.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Eating disorders:&#x000a0;Anorexia.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Addictions:&#x000a0;Alcohol or drug abuse.</p>
          </list-item>
        </list>
        <p>
<bold>Dietary factors:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Dehydration: Often resulting from excessive perspiration and inadequate water intake.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Malnutrition:&#x000a0;Associated with&#x000a0;deficiencies in vitamins A and D, zinc, or iron.</p>
          </list-item>
        </list>
        <p>
<bold>Medication-related effects:</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Adverse drug effects:&#x000a0;Linked to diuretics, beta-blockers, contraceptives, retinoids, prolonged use of topical steroids, lipid-lowering agents, and radiation therapy.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43016.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Xeroderma can manifest as an isolated condition, co-occur with other dermatological conditions such as atopic or irritant contact dermatitis, or be present in individuals with a family history of dry skin. Although&#x000a0;the precise incidence of xeroderma remains unknown, xeroderma is a common condition affecting individuals of all age groups&#x02014;both males and females.</p>
        <p>Research has shown a greater prevalence of xeroderma in older patients, especially in individuals 60 or older. Furthermore, xeroderma is frequently observed in individuals with underlying medical conditions, including diabetes mellitus, renal failure, and hypothyroidism, or those taking specific medications.<xref ref-type="bibr" rid="article-43016.r6">[6]</xref></p>
      </sec>
      <sec id="article-43016.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Xerotic skin develops as a result of impaired skin barrier function. This natural skin barrier consists of 15 to 20 layers of corneocytes embedded in a lipid intercellular substance, organized in a regular columnar pattern within the stratum corneum of the skin. These corneocytes originate from keratinocytes, which eventually undergo differentiation into nucleus- and organelle-free cells with a rigid horn protein coat as they progress toward the skin surface.</p>
        <p>In the lower stratum corneum, profilaggrin within keratinocytes undergoes conversion into filaggrin. Filaggrins play a crucial role in strengthening the skin barrier by facilitating the crosslinking of keratin filaments through disulfide bridges.<xref ref-type="bibr" rid="article-43016.r3">[3]</xref> To maintain skin health, the moisture level in the stratum corneum should ideally range from 10% to a maximum of 30%. Water loss from the stratum corneum to the environment happens primarily in low-humidity conditions, which requires replenishment from the lower epidermal layers and the dermis. A reduction in the water content of this layer results in abnormal corneocyte desquamation, thereby causing damage to the skin barrier and an elevation in transepidermal water loss.<xref ref-type="bibr" rid="article-43016.r7">[7]</xref></p>
        <p>Sphingolipids, free sterols, and free fatty acids are essential for maintaining the skin barrier. Among these components, ceramides play a significant role as a major lipid component in the stratum corneum, constituting a substantial portion of its weight. Ceramides undergo glycosylation and transform into sphingolipids, which are pivotal for preserving the integrity of the skin barrier. An escalation in transepidermal water loss serves&#x000a0;as a signal for skin barrier repair, triggering a cascade of cytokine changes that ultimately lead to ceramide production.<xref ref-type="bibr" rid="article-43016.r7">[7]</xref></p>
        <p>Natural moisturizing factors (NMFs), including lactic acid, sugars, amino acids, and urea, are essential for the skin's ability to retain water.&#x000a0;Approximately 10% of the dry weight of the stratum corneum consists of NMFs derived from the breakdown of filaggrin.&#x000a0;Alterations in the structure or composition of any of these components can lead to reduced stratum corneum hydration, resulting in dry skin with clinical symptoms like dullness, roughness, scaliness, tightness, fissuring, itching, and, in severe cases, even bleeding.<xref ref-type="bibr" rid="article-43016.r8">[8]</xref><xref ref-type="bibr" rid="article-43016.r9">[9]</xref><xref ref-type="bibr" rid="article-43016.r10">[10]</xref></p>
      </sec>
      <sec id="article-43016.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>Usually, xeroderma can be diagnosed clinically through a comprehensive history and physical examination. However, a skin biopsy can be performed in cases where uncertainty arises or there is a need to distinguish xeroderma from other conditions with similar presentations.<xref ref-type="bibr" rid="article-43016.r9">[9]</xref></p>
      </sec>
      <sec id="article-43016.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A comprehensive history and focused physical examination are adequate for an accurate diagnosis of xeroderma.&#x000a0;</p>
        <p>When gathering information about a patient's medical history, it is crucial to have a detailed discussion about the criteria mentioned below.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Atopic history: Allergies, atopic dermatitis, and asthma</p>
          </list-item>
          <list-item>
            <p>External factors: Occupational exposure, environment, diet, and skincare regimen</p>
          </list-item>
          <list-item>
            <p>Age: Higher likelihood with older age</p>
          </list-item>
          <list-item>
            <p>Pregnancy or menopause: Hormonal influences</p>
          </list-item>
          <list-item>
            <p>Comorbidities: Renal failure, chronic kidney disease, thyroid disorders, diabetes mellitus, and inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Medications: Diuretics and lipid-lowering agents</p>
          </list-item>
          <list-item>
            <p>Prior history of xeroderma and any previous attempted treatments</p>
          </list-item>
          <list-item>
            <p>Symptoms: Itching, burning sensations, pain, and skin tightness</p>
          </list-item>
          <list-item>
            <p>Duration: Acute or chronic conditions</p>
          </list-item>
          <list-item>
            <p>Timing:&#x000a0;Symptoms occurring intermittently, persisting constantly, or coinciding with specific triggers</p>
          </list-item>
        </list>
        <p>Individuals with xeroderma may encounter subjective symptoms, including pain, a burning sensation, tightness, and pruritus (see <bold>Image.&#x000a0;</bold>Xerosis Cutis). When xeroderma&#x000a0;is associated with pruritus, it can significantly diminish the patient's quality of life. The most frequently affected body areas include the lower legs, forearms, hands, and feet. A physical examination typically reveals&#x000a0;dry, rough, and scaly skin with a somewhat grayish hue. Moreover, reduced skin elasticity, wrinkling, erythema, and fissures may also be observed.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref></p>
      </sec>
      <sec id="article-43016.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of xeroderma primarily relies on clinical assessment, with a comprehensive history and physical examination adequate to identify this prevalent condition. Healthcare providers may conduct laboratory testing to evaluate the potential underlying causes of the condition, including assessments of thyroid hormone and vitamin levels. In rare instances, a skin biopsy may be warranted to differentiate xeroderma from conditions that mimic its presentation. However, the assessment of xeroderma usually does not include techniques such as "teewametry" for measuring transepidermal water loss or "corneometry" for hydration measurement. These methods are not typically recommended or used for diagnosing xerosis and are more relevant in clinical trials or research.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref></p>
        <p>Dermoscopy&#x000a0;enables the&#x000a0;assessment of subtle morphological changes in the skin&#x000a0;that may not be apparent&#x000a0;to the naked eye. To categorize the degree of xerosis, a&#x000a0;grading system based on specific criteria has been established, as mentioned below.&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>Mild: Scaling confined to skin furrows.</p>
          </list-item>
          <list-item>
            <p>Moderate: Scaling extending beyond skin furrows with distinct skin markings.</p>
          </list-item>
          <list-item>
            <p>Severe: Plate-like scaling extending beyond skin furrows and accompanied by the development of deep skin fissures.</p>
          </list-item>
        </list>
        <p>This dermoscopic grading system enables clinicians to accurately assess variations in the severity of xerosis attributed to various exacerbating factors and to evaluate the clinical response to treatment.<xref ref-type="bibr" rid="article-43016.r11">[11]</xref></p>
      </sec>
      <sec id="article-43016.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The treatment of xeroderma should prioritize restoring physiological lipids in the epidermis, improving skin hydration, optimizing skin barrier function, and promoting epidermal differentiation.<xref ref-type="bibr" rid="article-43016.r9">[9]</xref><xref ref-type="bibr" rid="article-43016.r12">[12]</xref>&#x000a0;Proper skincare practices are crucial in managing xeroderma, and a few&#x000a0;recommended strategies&#x000a0;are listed below.</p>
        <p><bold>Infrequent&#x000a0;bathing and using lukewarm water:</bold>&#x000a0;To effectively manage dry skin, it is advisable that individuals adopt infrequent bathing practices and opt for lukewarm water, steering clear of aggressive skin washing and hot water. These measures help prevent abrasion and the depletion of the skin's protective oils.</p>
        <p><bold>Gentle cleansers:</bold>&#x000a0;Gentle and synthetic detergent cleansers are recommended because of their acidic pH, which closely&#x000a0;matches the skin's natural pH. Syndet cleansers, in particular, are less irritating than traditional soaps and have been observed to reduce pruritus due to their lower pH levels.<xref ref-type="bibr" rid="article-43016.r13">[13]</xref><xref ref-type="bibr" rid="article-43016.r14">[14]</xref>&#x000a0;Traditional soaps should be avoided&#x000a0;as they raise the skin's pH, exacerbating dry skin and&#x000a0;itching.&#x000a0;</p>
        <p><bold>Skin moisturizers:</bold> Routine&#x000a0;application of oil-based creams is advisable due to their thicker consistency, which is more effective at moisturizing the skin than water-based lotions. With their greasier texture, ointments are especially valuable for preventing transepidermal water loss.<xref ref-type="bibr" rid="article-43016.r10">[10]</xref> For optimal results, moisturizers can be applied to damp skin after bathing, which will help reduce&#x000a0;evaporation.</p>
        <p><bold>Room humidifiers:</bold> Room humidifiers are particularly beneficial during winter as they help retain the skin's moisture.</p>
        <p><bold>Hydration:</bold>&#x000a0;Individuals dealing with xeroderma should stay&#x000a0;hydrated by consuming adequate&#x000a0;fluids.</p>
        <p>Skin moisturization can be achieved through various methods, each offering distinct advantages. One approach involves occlusion, where a water-impermeable barrier is applied to the skin's surface, creating an environment that supports barrier repair. Petrolatum is renowned as the most occlusive moisturizer.</p>
        <p>Humectancy is an alternative method for skin moisturization, where humectants function like sponges, drawing and retaining water within the skin. Within the dermis, glycosaminoglycans, including hyaluronic acid, serve as effective humectants. Additional humectants comprise glycerin, honey, sodium lactate, urea, and propylene glycol. Among these humectants, glycerin is the most potent one, which can draw water from the deeper epidermis and dermis layers of the skin, thereby filling gaps in the stratum corneum. Notably, unopposed humectants have the potential to draw moisture from the skin into the drier surrounding environment. Consequently, an ideal moisturizer should incorporate both humectants and occlusives for adequate skin hydration.</p>
        <p>Hydrophilic matrices are less commonly used for skin moisturization, as they create a physical protective coating to prevent water loss. Colloidal oatmeal baths and other high-molecular-weight substances, such as growth factors and collagen fragments, can serve as hydrophilic matrices for skin moisturization. However, it is noteworthy that occlusives and humectants are generally more effective than hydrophilic matrices in this context.<xref ref-type="bibr" rid="article-43016.r7">[7]</xref></p>
        <p>Various active ingredients with unique benefits are used in skincare products to improve skin texture and hydration, some of which are mentioned below.<xref ref-type="bibr" rid="article-43016.r2">[2]</xref><xref ref-type="bibr" rid="article-43016.r7">[7]</xref></p>
        <p><bold>Petrolatum:</bold>&#x000a0;This is recognized as the most effective moisturizing ingredient that acts as an occlusive by forming an oily barrier that prevents water from evaporating, thereby preserving the skin's moisture content while facilitating barrier repair.</p>
        <p><bold>Silicone:</bold>&#x000a0;This is&#x000a0;a non-greasy occlusive agent capable of filling gaps between desquamating corneocytes, resulting in smoother skin surfaces. The 2 most frequently utilized derivatives of silicone are dimethicone and cyclomethicone.</p>
        <p><bold>Ceramides:</bold>&#x000a0;They act to enhance intercellular lipids, thereby maintaining the natural skin barrier. Moisturizer formulations often include 9 distinct ceramides, each characterized by its polar head group.</p>
        <p><bold>NMFs:</bold> They are synthetically&#x000a0;formulated blends of amino acids that attempt to moisturize the skin by mimicking naturally occurring substances.</p>
        <p><bold>Urea and lactic acid:</bold>&#x000a0;These ingredients reveal water-binding sites on corneocytes, thereby enhancing skin hydration. Due to their keratolytic properties, they hold particular significance, especially in addressing foot calluses.</p>
        <p><bold>Licochalcone A:</bold>&#x000a0;This ingredient obtained from the roots of the Chinese licorice plant (<italic toggle="yes">Glycyrrhiza</italic>
<italic toggle="yes">inflata</italic>) possesses anti-inflammatory properties that can soothe irritated skin and reduce erythema.</p>
        <p><bold>Dexpanthenol:</bold>&#x000a0;This is the precursor of vitamin B5 and supports wound healing by stimulating epithelization and fibroblast proliferation. As a result, it finds utility in conditions such as atopic dermatitis, diabetic foot care, diaper dermatitis, burn injuries, and skin grafts.</p>
        <p><bold>Polidocanol:</bold>&#x000a0;This ingredient is a nonionic surfactant with local anesthetic properties that aid in alleviating pruritus linked to xerosis.</p>
        <p>The selection of ingredients should correspond to the patient's symptoms. Urea can be advantageous for addressing scaling, licochalcone A may be considered for erythema, and polidocanol can help alleviate pruritus. Urea or dexpanthenol can offer relief for fissures. Furthermore, clinicians may consider including topical corticosteroids or calcineurin inhibitors in the treatment regimen if dermatitis accompanies xeroderma.<xref ref-type="bibr" rid="article-43016.r15">[15]</xref></p>
      </sec>
      <sec id="article-43016.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>A differential diagnosis for xerosis may encompass the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Ichthyosis Vulgaris</p>
          </list-item>
          <list-item>
            <p>Atopic dermatitis</p>
          </list-item>
          <list-item>
            <p>Stasis dermatitis</p>
          </list-item>
          <list-item>
            <p>Irritant contact dermatitis</p>
          </list-item>
          <list-item>
            <p>Allergic contact dermatitis</p>
          </list-item>
          <list-item>
            <p>Nummular dermatitis</p>
          </list-item>
          <list-item>
            <p>Scabies</p>
          </list-item>
          <list-item>
            <p>Tinea corporis</p>
          </list-item>
          <list-item>
            <p>Psoriasis</p>
          </list-item>
          <list-item>
            <p>Cutaneous T-cell lymphoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-43016.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Xeroderma is typically a benign condition that may persist for years. The prognosis is favorable when triggers are avoided and a skincare regimen, which prioritizes gentle cleansing and adequate moisturization, is followed. In some instances, dry skin may be associated with a genetic disorder, such as xeroderma pigmentosum, resulting in more severe consequences, including an increased risk of developing skin cancer.</p>
      </sec>
      <sec id="article-43016.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Xeroderma can lead to pruritus, which increases the susceptibility to skin infections, as microorganisms infiltrate the skin's surface through breaks. Asteatotic eczema, which resembles cracked porcelain in severe cases, can exacerbate and coexist with xerosis during winter and cause bleeding from damaged dermal capillaries. This distinctive appearance, akin to cracked porcelain or a pattern resembling crazy paving, is called eczema craquel&#x000e9;. Other potential complications include food allergies, which are linked to filaggrin mutations and atopy, and allergic contact dermatitis, which is attributed to the impaired function of the skin barrier.</p>
      </sec>
      <sec id="article-43016.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Xeroderma can present as either an acute or chronic condition; for many individuals, it becomes a persistent, lifelong issue characterized by dry skin. In most instances, conservative management through gentle cleansing and proper moisturization of the skin effectively alleviates symptoms. Patients should recognize and avoid triggers, which can include using harsh soaps and detergents, extreme weather conditions, rough and tight clothing, stress, excessive consumption of alcohol, and eating spicy foods and citrus fruits.</p>
      </sec>
      <sec id="article-43016.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Xeroderma is a&#x000a0;prevalent condition that can be&#x000a0;identified by various members of healthcare professionals, including nurses, physician assistants, nurse practitioners, podiatrists, primary care providers, and dermatologists. Every healthcare provider plays an essential role in diagnosing dry skin in patients and providing valuable education to them regarding practical treatment approaches. For&#x000a0;instance, pharmacists are adept at identifying medication-related factors contributing to xeroderma, which include adverse effects or improper dosing. Pharmacists&#x000a0;are also proficient in formulating creams with active ingredients to enhance emollient and humectant properties.</p>
        <p>Nursing&#x000a0;professionals are well-equipped to educate patients on proper skin cleansing and moisturization techniques, which may involve the application of occlusive dressings.&#x000a0;Primary care providers and specialists&#x000a0;can&#x000a0;collaborate effectively to&#x000a0;address patients' comorbidities and systemic diseases. Interprofessional communication and coordinated care are crucial for delivering high-quality healthcare and ensuring patient satisfaction in cases of xeroderma, which is typically a benign condition.</p>
      </sec>
      <sec id="article-43016.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=43016&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=43016">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/xeroderma-dry-skin/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=43016">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/43016/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=43016">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-43016.s16">
        <fig id="article-43016.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Xerosis Cutis <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dermnetnz.org/images">DermNet New Zealand</ext-link></p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="dry__skin__stat__pearls" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-43016.s17">
        <title>References</title>
        <ref id="article-43016.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parker</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Scharfbillig</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Moisturisers for the treatment of foot xerosis: a systematic review.</article-title>
            <source>J Foot Ankle Res</source>
            <year>2017</year>
            <volume>10</volume>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">28191040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augustin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilsmann-Theis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kerscher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Itschert</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Dippel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Staubach</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of xerosis cutis - a position paper.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>17 Suppl 7</volume>
            <fpage>3</fpage>
            <page-range>3-33</page-range>
            <pub-id pub-id-type="pmid">31738016</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Augustin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kirsten</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>K&#x000f6;rber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilsmann-Theis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Itschert</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Staubach-Renz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Maul</surname>
                <given-names>JT</given-names>
              </name>
              <name>
                <surname>Zander</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence, predictors and comorbidity of dry skin in the general population.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>147</fpage>
            <page-range>147-150</page-range>
            <pub-id pub-id-type="pmid">29953684</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White-Chu</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Reddy</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dry skin in the elderly: complexities of a common problem.</article-title>
            <source>Clin Dermatol</source>
            <year>2011</year>
            <season>Jan-Feb</season>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-42</page-range>
            <pub-id pub-id-type="pmid">21146730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kopeck&#x000fd;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benda</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>N&#x0011b;m&#x0010d;ansk&#x000fd;</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Xerosis in Patient with Vitamin A Deficiency - a Case Report.</article-title>
            <source>Cesk Slov Oftalmol</source>
            <year>2018</year>
            <season>Spring</season>
            <volume>73</volume>
            <issue>5-6</issue>
            <fpage>222</fpage>
            <page-range>222-224</page-range>
            <pub-id pub-id-type="pmid">30541304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paul</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Maumus-Robert</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mazereeuw-Hautier</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guyen</surname>
                <given-names>CN</given-names>
              </name>
              <name>
                <surname>Saudez</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Schmitt</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and risk factors for xerosis in the elderly: a cross-sectional epidemiological study in primary care.</article-title>
            <source>Dermatology</source>
            <year>2011</year>
            <volume>223</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-5</page-range>
            <pub-id pub-id-type="pmid">22104182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Draelos</surname>
                <given-names>ZD</given-names>
              </name>
            </person-group>
            <article-title>The science behind skin care: Moisturizers.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>17</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-144</page-range>
            <pub-id pub-id-type="pmid">29319217</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Madison</surname>
                <given-names>KC</given-names>
              </name>
            </person-group>
            <article-title>Barrier function of the skin: "la raison d'&#x000ea;tre" of the epidermis.</article-title>
            <source>J Invest Dermatol</source>
            <year>2003</year>
            <month>Aug</month>
            <volume>121</volume>
            <issue>2</issue>
            <fpage>231</fpage>
            <page-range>231-41</page-range>
            <pub-id pub-id-type="pmid">12880413</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barco</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Gim&#x000e9;nez-Arnau</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>[Xerosis: a dysfunction of the epidermal barrier].</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2008</year>
            <month>Nov</month>
            <volume>99</volume>
            <issue>9</issue>
            <fpage>671</fpage>
            <page-range>671-82</page-range>
            <pub-id pub-id-type="pmid">19087805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Proksch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Lachapelle</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>The management of dry skin with topical emollients--recent perspectives.</article-title>
            <source>J Dtsch Dermatol Ges</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>10</issue>
            <fpage>768</fpage>
            <page-range>768-74</page-range>
            <pub-id pub-id-type="pmid">16194154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopic assessment of xerosis severity, pigmentation pattern and vascular morphology in subjects with physiological aging and photoaging.</article-title>
            <source>Eur J Dermatol</source>
            <year>2019</year>
            <month>Jun</month>
            <day>01</day>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>274</fpage>
            <page-range>274-280</page-range>
            <pub-id pub-id-type="pmid">31389786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meki&#x00107;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jacobs</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Gunn</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Mayes</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Pardo</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Nijsten</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and determinants for xerosis cutis in the middle-aged and elderly population: A cross-sectional study.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>81</volume>
            <issue>4</issue>
            <fpage>963</fpage>
            <page-range>963-969.e2</page-range>
            <pub-id pub-id-type="pmid">30586613</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boccanfuso</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Cosmet</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Volpe</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Bensel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Skin xerosis. Clinical report on the effect of a moisturizing soap bar.</article-title>
            <source>Cutis</source>
            <year>1978</year>
            <month>May</month>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>703</fpage>
            <page-range>703-7</page-range>
            <pub-id pub-id-type="pmid">348407</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abbas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Goldberg</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Massaro</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Personal cleanser technology and clinical performance.</article-title>
            <source>Dermatol Ther</source>
            <year>2004</year>
            <volume>17 Suppl 1</volume>
            <fpage>35</fpage>
            <page-range>35-42</page-range>
            <pub-id pub-id-type="pmid">14728697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-43016.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakagawa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan.</article-title>
            <source>Clin Drug Investig</source>
            <year>2006</year>
            <volume>26</volume>
            <issue>5</issue>
            <fpage>235</fpage>
            <page-range>235-46</page-range>
            <pub-id pub-id-type="pmid">17163257</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
